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ABSTRACT
Epstein–Barr Virus (EBV) DNase (BGLF5) is an
alkaline nuclease and has been suggested to be
important in the viral life cycle. However, its effect
on host cells remains unknown. Serological and
histopathological studies implied that EBV DNase
seems to be correlated with carcinogenesis.
Therefore, we investigate the effect of EBV DNase
on epithelial cells. Here, we report that expression
of EBV DNase induces increased formation of
micronucleus, an indicator of genomic instability,
in human epithelial cells. We also demonstrate,
using cH2AX formation and comet assay, that EBV
DNase induces DNA damage. Furthermore, using
host cell reactivation assay, we find that EBV
DNase expression repressed damaged DNA repair
in various epithelial cells. Western blot and quanti-
tative PCR analyses reveal that expression of
repair-related genes is reduced significantly in
cells expressing EBV DNase. Host shut-off
mutants eliminate shut-off expression of repair
genes and repress damaged DNA repair, suggesting
that shut-off function of BGLF5 contributes to
repression of DNA repair. In addition, EBV DNase
caused chromosomal aberrations and increased
the microsatellite instability (MSI) and frequency of
genetic mutation in human epithelial cells. Together,
we propose that EBV DNase induces genomic insta-
bility in epithelial cells, which may be through induc-
tion of DNA damage and also repression of DNA
repair, subsequently increases MSI and genetic
mutations, and may contribute consequently to the
carcinogenesis of human epithelial cells.
INTRODUCTION
Nucleases which break down DNA molecules are
distributed ubiquitously in eukaryotic cells and microor-
ganisms and some viruses also express nucleases during
their life cycle. In the prokaryotic viruses,   exonuclease
(Reda) encoded by   phage was shown to be important for
processing the viral genome (1). In eukaryotic viruses, the
best-studied nucleases are the alkaline nucleases (ANs) of
the Herpesviridae and Baculoviridae. ANs are deﬁned as
enzymes that degrade DNA under alkaline condition. The
AN encoded by a baculovirus was found to be involved in
the resolution of replication intermediates and genome
maturation (2). In the herpesviruses, the AN of herpes
simplex virus 1 (HSV-1) had been shown to be required
for eﬃcient processing of viral DNA replication interme-
diates (3) and for the eﬃcient production of viral progeny
(4). Aside from their role in the viral life cycle, however,
the eﬀects of these ANs on the host cells are less well
understood.
Epstein–Barr virus (EBV), a member of the
herpesviridae, has been associated with many human
malignancies, including Burkitt’s lymphoma (BL) and
nasopharyngeal carcinoma (NPC) (5). EBV DNase
(BGLF5) is an AN encoded by the BGLF5 open
reading frame of EBV. The EBV life cycle has two
stages, latency and the lytic cycle. EBV DNase is expressed
in the early stage of the lytic cycle and is classiﬁed as an
early lytic protein. EBV DNase had been shown to be
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genomes (6). Biochemically, it exhibits both exonuclease
and endonuclease activities, a requirement for divalent
cations, and a preference for alkaline conditions (7–10).
As substrates, dsDNA is digested processively but
ssDNA, distributively (11). The endonuclease activity
of EBV DNase seems to have a DNA structural prefer-
ence but no sequence speciﬁcity. The exonuclease
degrades DNA from 50-t o3 0-direction, generating
50-monophosphate nucleosides (11). In contrast to the
well-studied functions in vitro, the eﬀects of EBV DNase
on cells have been elucidated less clearly. Serological
studies indicated that NPC patients have higher titers of
antibody against EBV DNase than normal controls (12)
and antibody levels may be raised prior to the appearance
of the clinical symptoms of NPC (13). In histopathological
studies, signiﬁcant amounts of EBV DNase protein and
nuclease activity were demonstrated in both fresh biopsies
and transplanted tumor lines (14). Based on these obser-
vations, EBV DNase seems to play an important role in
NPC carcinogenesis. However, the question of how EBV
DNase contributes to carcinogenesis is not very clear.
Genomic instability appears to be a hallmark of cancers
(15). It has been found in most types of cancers, including
NPC, and correlated with the malignant levels of cancers
(16–18). Therefore, genomic instability has been consid-
ered to be either a cause or the result of carcinogenesis
(19,20). Generally, genomic instability is characterized
by an increased frequency of genetic changes encom-
passing nucleotide-excision repair-associated instability,
microsatellite instability (MSI), and chromosomal
aberration-associated instability (19). Intrachromosomal
genomic instability may result from increased rates of
DNA damage overwhelming the ability of cellular repair
systems to maintain genome integrity. In addition, impair-
ment of repair systems also plays another major role
in intrachromosomal genomic instability. There are
ﬁve major repair systems to protect human cells from
injury (21,22): (i) nucleotide excision repair (NER),
(ii) base excision repair (BER), (iii) mismatch repair
(MMR), (iv) homologous recombination (HR) and (v)
non-homologous end-joining (NHEJ). When these repair
pathways are interrupted, defective repairs are unable to
cope with rates of DNA damage, leading to genomic insta-
bility. At the chromosome level, chromosomal instability
results mainly from inappropriate segregation, DNA
recombination and impaired mitosis. Some studies sug-
gested that DNA double-stranded breaks (DSBs) also
may cause chromosomal aberrations (23,24).
Increased rates of DNA damage and inhibition of DNA
repair may arise from either internal (e.g. free radicals,
replication stress) or external (e.g. microbial, UV, chemi-
cals) sources (25). Recently, several human cancer-
associated viruses, including human T-cell leukemia
virus 1 (HTLV-1), hepatitis C viruses (HCV), and
human papilloma viruses (HPV) have been proven to be
involved in the induction of genomic instability or genetic
aberrations (26–28). Among the herpesviruses, Kaposi’s
sarcoma associated herpesvirus (KSHV) was found to
induce genomic instability in endothelial cells (29).
Latent infection of human B cells by EBV also has been
shown to enhance genetic instability (30,31). Recently, we
observed that recurrent chemical reactivations of EBV
promote genomic instability and enhanced tumor progres-
sion of NPC cells (32). This recent observation implied
that EBV could enhance genomic instability during the
lytic cycle. In addition, we also found that EBV DNase
had the most potent ability to induce genomic instability
among several EBV lytic genes examined (32). It would be
interesting to determine the eﬀects of EBV DNase on cells,
especially at the genomic level. Previously, Russo et al.
demonstrated that DNA breakage could be enhanced by
endonuclease and may contribute to genomic instability
(33). Overexpression of RAG-1/2 endonuclease was
found to cause genomic instability, which may be
through the induction of DNA DSBs (34), and apurinic/
apyrimidinic endonuclease (APE) was found to interfere
with DNA repair, leading to genomic instability (35).
Furthermore, hepatocellular carcinoma tissues have been
shown to have overexpression of repair-related nucleases
(36). All these results indicate that nuclease expression is
correlated with human malignancy. On the other hand,
ectopic expression of restriction endonucleases was
found to induce DNA DSBs, chromosome aberration,
oncogenic transformation and genetic mutation (37–40).
Moreover, it was also demonstrated that several lytic
proteins, including the AN of herpes simplex virus-2
(HSV-2), were involved in the induction of chromosomal
aberrations (41). These studies suggested that nucleases,
from either an intrinsic or extrinsic source, have the poten-
tial to cause genomic instability, although the detailed
mechanisms remain unclear.
Combining these observations, we tried to address the
question of whether a viral nuclease could induce genomic
instability in the cells. In this communication, we ﬁrst
demonstrate that EBV DNase could induce genomic insta-
bility in human epithelial cells. We also provide evidence
that EBV DNase may induce genomic instability through
two mechanisms: directly, by damage to DNA, and
indirectly, by inhibition of DNA repair. Moreover, we
show that chromosomal aberrations developed when
DNase was expressed in the epithelial cells. Finally, the
genetic mutation assays show that EBV DNase could elicit
mutation and MSI. These results reveal a novel mecha-
nism through which AN induces genomic instability
and also a new insight into the role of EBV in the
carcinogenesis of NPC.
MATERIALS AND METHODS
Cell culture and antibodies
All of the following cell lines and their derivatives were
maintained in DMEM (Dulbecco’s modiﬁed Eagle’s
medium) supplemented with 10% fetal calf serum.
TW01, is a human NPC cell line (42). H1299, is a
human lung carcinoma cell line (43). HEp2 cell, is a
human laryngeal epithelial cell line (44).
Antibody to EBV DNase, anti-DNase 311H, was
generated in our laboratory previously (45) and
anti-b-actin and GAPDH antibodies were purchased
from Sigma-Aldrich Co. The antibody of gH2AX was
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MMR-related proteins, including MSH2, MSH6, MLH1
and PMS2, were purchased from BD, Biosciences.
DNA constructs
The EBV DNase expression plasmids were constructed by
cloning the respective coding sequences into the
pEGFP-CPO-IRES-puro vector, which was derived from
pEGFP-C1, with insertion of an IRES-puro cassette, by
CPO site ligation. Plasmid of Mutant 1 encoded the
sequence of EBV DNase with F452A point mutation
(46) and subcloned into pEGFP-CPO-IRES-puro vector.
Similarly, Mutants 2 and 3 encoded the sequences of EBV
DNase with E225A/K227A double mutations and E225A/
K227A/F452A triple mutations which were generated by
site-directed mutagenesis and subcloned into pEGFP-
CPO-IRES-puro vector. The coding sequences of DNase
and the F452A mutant (46) were inserted into the HindIII
site of the p30SS vector (Stratagene), to generate pIn-
DNase and pIn-F452A. For MSI assay, the DNA
fragment TAG-Bsd, which contains a stop codon TAG
replacing the start codon ATG in front of the blasticidin
resistance gene coding sequence, were generated by
site-directed mutagenesis. The DNA fragment
CA16-Bsd, containing 16 dinucleotide repeats (CA) down-
stream from the initiation codon of the blasticidin resis-
tance gene, was generated by PCR using the upstream
primer (50-cacggtccgcacacacacacacacacacacacacacacacat
tgccaagcctttgtctcaagaag-30) with an artiﬁcial CpoI site,
downstream primer (50-cacggaccgttagccctcccacacata
acc-30) with an artiﬁcial CpoI site and pLenti6/TR
(Invitrogen) as the template. The DNA fragment
TAG-Bsd and CA16-Bsd were inserted into a modiﬁed
pcDNA3.1 (with an HA tag and a CpoI site) to generate
pBsd2-puro and pBsd4-puro. The construct was veriﬁed
by DNA sequencing. The pBsd4-puro plasmid contains 16
dinucleotide repeats (CA) downstream of the initiation
codon of the blasticidin resistance gene, so that the
blasticidin resistance gene coding sequence is out of
frame. These plasmids contain a puromycin resistance
gene which was used to establish stable transfectants.
Western blotting analysis
The cellular extracts were separated by SDS–PAGE and
transferred to Hybond-C super membrane (Amersham
Biosciences Ltd.). The blot was incubated with blocking
buﬀer (10mM Tris–HCl, pH 8.0, 0.9% NaCl and 4%
skim milk) for 1 h and reacted with indicated antibodies
for 1h at room temperature. After washing three
times with washing buﬀer, the blot was incubated
with horseradish peroxidase-labelled goat anti-mouse
IgG (Amersham Biosciences Ltd) diluted 1:2500 with
blocking buﬀer for 1 h at room temperature. After incu-
bation, the blot was washed three times in washing buﬀer
and once with water, and then developed with a
freshly prepared substrate (Amersham Biosciences Ltd.).
The luminescence was detected by a short exposure to
X-ray ﬁlm.
Immunoﬂuorescence staining
HEp2 cells were grown on the cover slides and transfected
with indicated plasmids for 24h. For gH2AX staining,
cells were washed one time with phosphate buﬀered
saline (PBS) and ﬁxed with 2% formaldehyde for
10min. Then, ﬁxed cells were permeabilized with 0.4%
Triton X-100 in PBS for 5min. After washed with 4%
FCS in PBS (4% FCS–PBS) for three times, cells were
blocked in 4% FCS–PBS for 30 min. The cells were
incubated with 2mg/ml of anti-phospho-Histone H2A.X
(Ser139) (Upstate, Charlottesville, VA) in 4% FCS-PBS
at 37 C for 1h, and then washed three times with 4%
FCS–PBS. The secondary antibody was
Rhodamine-conjugated goat antimouse IgG, diluted
1:100 in 4% FCS–PBS. After incubation with secondary
antibody at 37 C for 1 h, the cells were washed three times
with 4% FCS–PBS and visualized with ﬂuorescence
microscope. Nucleus was visualized by DAPI staining.
Cells were treated with bleomycin (1mM) for 24h as the
control of DNA-strand breaks.
Detection of the formation of micronucleus
Detection of micronucleus (MN) formation was per-
formed as described previously (47). Cells were seeded
onto coverslips and allowed to adhere for 24h prior to
transfection or IPTG treatment. After 24h transfection
or 48h IPTG treatment, the culture medium was
removed and the cells were washed twice in PBS.
Cells were ﬁxed with ice methanol for 15min. After
washing twice in phosphate-buﬀered saline (PBS, pH
7.4), the cells were stained with Hoechst (0.2mg/ml,
Sigma-Aldrich, St Louis, MO) for 15min. Micronuclei
were judged using a ﬂuorescence microscope.
Nuclease activity assay
Appropriate number of cells (5 10
6 to 5 10
7 cells/ml) at
each condition was collected. Then the cells were
resuspended in extraction buﬀer (50 mM Tris–HCl, pH
7.5, 0.3M KCl, 5mM 2-mercaptoethanol, 1mM PMSF,
20% glycerol).After centrifugation at 9170g, 4 C for 10
min, supernatants were diluted with dilution buﬀer
(50mM Tris–HCl, pH 8.0, 10mM MgCl2,1 0 m M
2-mercaptoethanol, 0.05% BSA) (100–200mg/ml). The
10ml diluted solutions were incubated with 90mlo f
1mg/ml salmon sperm DNA for 1h at 37 C. Then
samples were added with 100ml picogreen dye
(Molecular Probe, 200-fold diluted in 10mM Tris–HCl,
pH 8.0, 10 mM EDTA), mixed well, and ﬂuorescence
(Ex: 480nm, Em: 520nm) detected with a microplate
reader. Enzyme activity is deﬁned as percentage of
hydrolyzed DNA which was digested by EBV DNase.
cH2AX detection by ﬂow cytometry
To evaluate the DNA DSB, cells were treated and har-
vested, ﬁxed in 70% ethanol. The ﬁxed cells were
permeabilized with 1% Triton X-100 and 4% FBS, and
then followed by resuspension with anti-gH2AX antibody
(dilution 1:500, Upstate) and incubation for 2 h. Cells
were washed with PBS and incubated with a 1:1000
1934 Nucleic Acids Research, 2010,Vol.38, No. 6dilution of goat anti-mouse IgG Rhodamine-conjugated
antibody for 1h. Cells were washed and analyzed using
a Becton Dickinson FACScan ﬂow cytometer (BD
Biosciences, San Jose, CA). Each experiment was in dupli-
cate with 10000 cells.
Comet assay
A single-cell gel electrophoresis (comet assay) kit was
employed for evaluating DNA damage (Trevigen, Inc.).
The comet assay is an eﬀective method for detection of
DNA damage in cells. This assay is based upon the ability
of denatured, cleaved DNA fragments migrate faster than
undamaged DNA. After 24h transfection of eﬀector
plasmids, cells were resuspended in 1 PBS and
combined with molten low melting agarose (at 37 C) at
a ratio of 1:10 (v/v) and immediately pipetted 75ml onto
CometSlide
TM. After cell lysis, samples were treated with
NaOH solution (300 mM NaOH, 1mM EDTA) to
unwind and denature the DNA. The samples were
applied to electrophoresis, stained with SYBR Green
DNA dye, and observed by a ﬂuorescence microscope to
score with comet appearance (48). One hundred comets
were scored randomly, and each comet assigned a value
of 0 to 4 according to its class. The undamaged cells are
classiﬁed as grade 0 (most intense centre and no tail), and
the most damaged cells as grade 4 (disintegrated centre
and longest tail). The standard scheme of scoring is
described in Supplementary Figure S1. The total score
was represented by comet scores to correlate with levels
of DNA damage. The results were averaged with at least
three independent experiments to calculate the mean and
the standard deviation.
Transfection
For TW01, H1299 and HEp2 cells, plasmid DNA was
transfected using Lipofectamine 2000 (Invitrogen),
according to the manufacturer’s instructions. Cells were
seeded one day before transfection and plasmid DNA
and Lipofectamine 2000 were mixed in Opti-MEM
medium (Invitrogen) and incubated for 20 min, then
added to the culture well containing cells.
Host cell reactivation assay
The host cell reactivation (HCR) assay was as described
previously (47). In brief, ﬁreﬂy luciferase reporter plasmid
(pCMV-Luc), damaged with diﬀerent methods or not,
such as 2000 J/m
2 of UV light, 10mg/ml of cisplatin and
100mM of MNNG pre-treatment, undamaged Renilla
luciferase pRL-CMV reporter (Promega) as the internal
control and eﬀector plasmids (DNase and mutants) were
cotransfected into cells with Lipofectamine 2000
(Invitrogen). At 24 or 48 h post-transfection, cells were
lysed in 50 ml lysis solution (0.1M HEPES, pH 7.8, 1%
Triton X-100, 1mM CaCl2 and 1mM MgCl2) and 25 ml
aliquots of the lysates were taken for next assay. Firstly,
25 ml of Luciferase Assay Reagent II (Promega) was
added to the samples for measurement of ﬁreﬂy luciferase
activity using a luminescence counter (Packard), and then
25 ml of Stop & Glo Reagent (Promega) was added to the
lysates. The luciferase activity was measured using a
luminescence counter (Packard). The factor of repair con-
version was deﬁned as the ﬁreﬂy luciferase activity of each
sample normalized to the Renilla luciferase activity. The
relative fold of HCR was calculated by dividing the repair
conversion of eﬀector transfectants by that of vector
transfectants. The results were averaged with at least
three independent experiments to calculate the mean and
the standard deviation.
In vitro microsatellite instability and gene mutation assay
This assay was established by Naganuma et al. (49)
previously. Brieﬂy, reporter plasmid pBsd2-puro has a
stop codon TAG replacing the start codon ATG in front
of the blasticidin resistance gene coding sequence, and
pBsd4-puro contains 16 dinucleotide repeats (CA) down-
stream from the initiation codon of the blasticidin resis-
tance gene which is out of frame, so that the blasticidin
resistance proteins in these two reporters were not
expressed. In protocol, the reporter plasmid pBsd2-puro
or pBsd4-puro as transfected into Hp30SS or HB7 cells,
then transfectants were selected with puromycin (1mg/ml).
Puromycin-resistant clones emerged 2–3 weeks later. For
gene mutation and MSI assay, cells harboring pBsd2-puro
or pBsd4-puro were seeded in 100-mm culture dishes
(2 10
3 or 1 10
4cells per dish), incubated with
blasticidin (5mg/ml). After 14 days of incubation, the
cells were stained with 0.05% p-iodonitrotetrazolium
violet dye and then colonies larger than 1mm were
counted. The frequency of gene mutation and MSI were
calculated by dividing the number of colonies by those of
total seeded cells.
Quantitative RT–PCR
Amounts of mRNA expressed from diﬀerent genes were
detected by quantitative real time PCR. Total RNA was
isolated from vector and DNase-transfected TW01
cells,and mock- or IPTG-treated Hp30SS and HB7 cells
using Trizol (Invitrogen) following the manufacturer’s
protocol, then subjected to DNase I treatment and
stored at –80 C. RNA purity was conﬁrmed by
determining the OD260/OD280 nm absorption ratio.
Reverse transcription (RT) was performed with
SuperScript II RNase H reverse transcriptase
(Invitrogen), 1–2mg RNA and oligo dT primers. Then
RT products were used for real-time quantitative PCR
(QPCR) reaction. The four MMR primers were designed
with Primer 3 software (Infobiogen, Evry, France). Others
were suggested by published literatures [ERCC1 and XPA
(50); XPB and CSB (51); XPF (52); CSA (36); BRCA2 and
Rad51 (53)]. The total primers of target genes are shown
in Table 1. The standard products of each gene from
RT-PCR were puriﬁed by gel extraction. The puriﬁed
products were subjected to further PCR and puriﬁed
again. After quantifying the cDNA concentration by
absorbance at 260nm and the copy number was
calculated by using the molecular mass of the PCR
fragment. These cDNA products were used for making
calibration curve. QPCR was performed using FastStart
DNA Master SYBR Green I kit (Roche) in the
LightCycler system (Roche). Reaction mixture contained
Nucleic Acids Research,2010, Vol.38, No. 6 19356ml prepared cDNA of each sample, 4ml master mix, 2ml
speciﬁc primers (10mM) and PCR-grade water to a ﬁnal
volume 20ml. After 10 min pre-incubation at 95 C, PCR
conditions were: 10s denaturation at 95 C, 5 s annealing
at 50 C and 10s extension of primers at 72 C for 30 cycles.
The speciﬁcity of the PCR reaction was controlled by
melting curve analysis (65–95 C, 0.1 C/s) in the
LightCycler and by agarose gel electrophoresis. In each
experiment, control, sample and serially diluted standard
products were detected together. The absolute amount of
each gene product could be determined by comparison
with the standard curve. Each analysis was done in dupli-
cate and a negative control containing water instead of
sample cDNA was included. The transcript level of each
sample was normalized with that of GAPDH. Experiment
for each gene was performed independently at least three
times. The expression level of each sample was expressed
as the relative expression compared with that of vector
controls.
Cytogenetic analysis
The chromosomal aberrations in EBV DNase transfected
cells were determined in the Center for Medical Genetics,
Changhua Christian Hospital. Brieﬂy, the cells were
treated with colcemid overnight to induce metaphase
arrest. The harvested cells were then treated with
hypotonic KCl (75 mM) buﬀer, ﬁxed in a 3:1 mixture
of methanol and acetic acid, plated onto glass slides for
Giemsa staining. Chromosomal aberrations were scored in
at least 200 metaphase plates for each cell line.
Chromosome aberrations including dicentric chromo-
somes, chromosome fragments, chromatid gaps, chromo-
some rings, double minutes and satellite associations were
counted (54).
RESULTS
EBV DNase causes formation of MN in various
epithelial cell lines
We aligned the amino acid sequences of several
herpesvirus ANs: a-herpesvirus HSV-1, b-herpesviruses
cytomegalovirus (CMV) and varicella zoster virus
(VZV), g-herpesviruses EBV, KSHV, herpesvirus saimiri
(HVS) and rhesus rhadinovirus (RRV) (Supplementary
Figure S2a). Using in vitro assays, we have demonstrated
that E225 and K227 of motif III are required for cleavage
of DNA, while the residue F452, which is in the
C-terminus of the EBV DNase but not in a conserved
motif, is also critical for enzyme activity (46). To elucidate
whether EBV DNase could induce genomic instability,
ﬁrstly, three diﬀerent DNase activity-null mutants were
constructed: Mutant 1 has an F452A substitution in the
C terminus (55), Mutant 2 has the E225A/K227A dou-
ble substitutions in the catalytic site and Mutant 3
has the E225A/K227A/F452A triple substitutions
(Supplementary Figure S2b). All of them were nearly
activity-null in nuclease activity assays, compared to the
wild type DNase (Supplementary Figure S2c), and their
expression was detected by western blotting with DNase
speciﬁc antibody (Supplementary Figure S2d). Compared
to level of DNase expression in EBV reactivated
EBV-infected NPC cells (NA), the expression levels
of these plasmids were appropriate (Supplementary
Figure S3).
Formation of MN is considered to be indicative of chro-
mosomal damage and is used widely in testing chemicals
which may induce cytogenetic damage (56–58). To inves-
tigate whether EBV DNase has the ability to cause
genomic instability, increased MN formation was
detected in various epithelial cells. We carried out tran-
sient transfection of the EBV DNase-expressing plasmid
into the human epithelial cell lines, TW01, H1299 and
HEp2, to determine whether EBV DNase per se could
induce the formation of MN. Transfection eﬃciency of
vector and DNase plasmids in TW01, H1299 and HEp2
cell lines were determined (Supplementary Figure S4,
vector: 72–82%; DNase: 55–61%; Mutant 1: 66–78%).
As shown in Figure 1a and Supplementary Table 1a,
EBV DNase induced formation of MN in higher percent-
ages of TW01, H1299 and HEp2 cells than
mock-transfected and vector controls. We then transfected
vector, wild type DNase and three mutants plasmids into
TW01 cells to determine whether nuclease activity is
Table 1. QPCR primers utilized in this study
Repair-related genes Primer sequences (50!30)
MSH2
Sense GCCATTTTGGAGAAAGGACA
Antisense CTCACATGGCACAAAACACC
MSH6
Sense CCCCACCAGTTGTGACTTCT
Antisense TGTTGGGCTGTCATCAAAAA
MLH1
Sense TGGGACGAAGAAAAGGAATG
Antisense GATCAGGCAGGTTAGCAAGC
PMS2
Sense CAGGACATGTCAGCCTCTCA
Antisense GGCTGCTTGATTTTCTCCAG
ERCC1
Sense ATACCCCTCGACGAGGATGAG
Antisense ACAGTGGGAAGGCTCTGTGTAGA
XPA
Sense GCTGCCCGGCCCTACTC
Antisense TGAAGCCTCCTCCTGTGTCAAT
XPB
Sense CCAGGAAGCGGCACTATGAGG
Antisense GGTCGTCCTTCAGCGGCATTT
XPF
Sense TATCTGGATCCTTTGTGGCACCA
Antisense TTTCTCGACGATATCCTTCCTCG
CSA
Sense TTAAGGTATGACCAAATCCTGCCT
Antisense ACAGCATTTCATGTTTAAGCCAGAT
CSB
Sense TTGAGCTGCAGGGTTTGGGTG
Antisense TGCATCCTCCTCCAGACTGGC
BRCA2
Sense CGTACACTGCTCAAATCATTC
Antisense GAAATGGAGGTGGACAATCAG
Rad51
Sense CTTTGGCCCACAACCCATTTC
Antisense ATGGCCTTTCCTTCACCTCCAC
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DNase, mutants retained some ability to induce MN for-
mation (Figure 1b, Supplementary Table S1b). To
monitor further the eﬀect of EBV DNase on human epi-
thelial cells, inducible expression of the enzyme was estab-
lished in HEp2 cells by transfection with vector (p30SS),
wild type DNase (pIn-DNase), or DNase with a point
mutation causing loss of enzyme activity (pIn-F452A).
Hygromycin-resistant clones emerged 3-4 weeks later
and stable transfectants, Hp30SS, HB7, and HA6 cells,
respectively, were established and expanded for further
analysis. In HB7, the formation of MN increased follow-
ing IPTG induction (Figure 1c, Supplementary Table
S1c), but there was no diﬀerence in MN formation
before and after IPTG induction of Hp30SS. HA6 cells
did not diﬀer in the formation of MN after induction
with 10 mM IPTG, but, interestingly, showed a little
increase in MN formation after induction with 20 mM
IPTG (Figure 1c, Supplementary Table S1c). These
results indicated that the nuclease activity of EBV
DNase was important for MN formation, although
other eﬀects could not be ruled out. Because increased
formation of MN is considered to be an indicator of
genomic instability, these results suggested that EBV
DNase may contribute to genomic instability.
EBV DNase induces DNA strand breaks in epithelial cells
Several factors have been shown to contribute to cellular
genomic instability (19,25). Induction of DNA damage
and repression of repair of damaged DNA are considered
to play the most important roles in genomic instability
(21,59,60). Although EBV DNase has been shown to
cleave DNA in vitro (8,9,11), it is not clear whether the
enzyme causes DNA strand breaks when expressed in
cells. Therefore, the ability of EBV DNase to damage
DNA was determined in epithelial cells. Since
phosphorylated histone H2AX (gH2AX) is a sensitive
marker of the presence of DNA DSBs (61), we determined
by ﬂow cytometry the amount of gH2AX in epithelial
cells transfected with various amounts of DNase. As
shown in Figure 2a, EBV DNase caused phosphorylation
of H2AX in various human epithelial cell lines in a
dose-dependent manner. Protein expression and nuclease
activities also were detected (Figure 2b and c). The
phosphorylation of H2AX in HEp2 cells transfected
with the EBV DNase plasmid also was shown by
immunoﬂuorescence staining. The cells which expressed
EBV DNase were found to coincide with
gH2AX-positive cells, indicating that EBV DNase
caused gH2AX formation in human epithelial cells
(Figure 2d). Furthermore, in the inducible lines, the
phosphorylation of H2AX increased following IPTG
induction of HB7 cells but there was no diﬀerence in
Hp30SS cells before and after IPTG induction, nor was
there a signiﬁcant increase in IPTG induced HA6 cells,
which were performed by ﬂow cytometry and western
analysis (Figure 2e). DNase expression was examined
and DNase protein expression increased in a dose-
dependent manner following IPTG induction
(Figure 2f). The nuclease activities in HB7 cells increased
following IPTG addition (Figure 2g). These results
indicated that EBV DNase can induce phosphorylation
of H2AX and support the hypothesis that EBV DNase
induces DNA strand breaks in epithelial cells.
Figure 1. EBV DNase induces formation of MN in epithelial cells. (a)
TW01, H1299 and HEp2 cells were mock transfected, transfected with
vector control and DNase-expressing plasmid, and treated with
bleomycin (1mM) as positive control. Twenty-four hours
post-transfection, cells were harvested and were stained by Hoechst
for counting micronuclei. (b) TW01 cells were mock transfected or
transfected with vector, DNase, Mutant 1(F452A), Mutant 2 (E225A/
K227A) and Mutant 3 (E225A/K227A/F452A), respectively. 24h
post-transfection, cells were harvested and were stained by Hoechst
for counting micronuclei. (c) Hp30SS (vector control), HB7
(DNase-inducible clone), and HA6 (activity-null mutant
F452A-inducible clone) were treated with various doses of IPTG.
After 48 h induction, cells were stained by Hoechst for counting
micronuclei. The counting numbers of MN positive-cells were repre-
sented in Supplementary Table S1. In all results, the values are a
mean±SD from at least three separate experiments. Asterisk denotes
P<0.05. Two asterisks denote P<0.01.
Nucleic Acids Research,2010, Vol.38, No. 6 1937Figure 2. EBV DNase increases gH2AX formation in epithelial cells. (a) TW01, H1299 and HEp2 cells were transfected with various doses of EBV
DNase plasmid. Vector was added to adjust for equal DNA amount in each sample. Twenty four hours post-transfection, cells were collected and
incubated with gH2AX antibody for cytometry analysis. In histogram, M is deﬁned as the portion of gH2AX-positive cells. (b) Cell lysates were
collected to examine protein expression by western blotting. (c) Cell lysates of various clones were collected and assayed for nuclease activity.
Nuclease activity is deﬁned as the percentage of hydrolyzed DNA which was digested by EBV DNase. (d) HEp2 cells were mock treated, treated with
bleomycin (1mM) for 24h or transfected with vector or DNase-expressing plasmid. Twenty four hours post-transfection, cells were examined for
phosphorylation of H2AX (red ﬂuorescence), and cell nuclei were visualized with DAPI staining. Transfectants with vector and DNase were
monitored with green ﬂuorescence (GFP-positive). (e) Hp30SS (vector control), HB7 (DNase-inducible clone), and HA6 (activity-null mutant
F452A-inducible clone) were treated with various doses of IPTG. After 48 h induction, cells were harvested and incubated with gH2AX
antibody for cytometry analysis. In histogram, M is deﬁned as the portion of gH2AX-positive cells. The protein expression of gH2AX in
Hp30SS and HB7 cells was also detected by western analysis (right panel). (f) Cell lysates were collected for western blotting to examine EBV
DNase expression. (g) Cell lysates were collected and assayed for nuclease activity. Nuclease activity is deﬁned as the percentage of hydrolyzed DNA
which was digested by EBV DNase.
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In order to conﬁrm that nuclease activity is critical for
damaging DNA, an alternative to gH2AX formation
was used for detection. The comet assay (or single cell
gel electrophoresis assay) is a sensitive, widely-used
method to detect DNA damage (48,62). Under alkaline
conditions, the comet assay can detect eﬀectively single
and double strand breaks in DNA (62). The principle
and detailed methodology are described in ‘Materials
and Methods’ section. For the comet assay, wild-type
DNase and three activity-null mutants were transfected
into TW01 cells. After 24 h, cells which were transfected
with the wild-type displayed robust comet tails compared
to the control, but the three mutants did not (Figure 3a).
This result is consistent with the detection of gH2AX for-
mation, implying that EBV DNase could induce DNA
strand breaks in human epithelial cells. We also selected
100 cells randomly to quantify their comet centre intensity
and tail lengths. After referring to standard images
(Supplementary Figure S1), the wild-type DNase had the
highest comet score. This meant that wild type DNase
caused the heaviest DNA damage. None of the mutants
had signiﬁcant eﬀects by visual quantiﬁcation, compared
to the vector control (Figure 3b). The results of the comet
assays suggested that the nuclease activity of EBV DNase
is important for damage to DNA in human epithelial cells.
EBV DNase inhibits repair of chemical-elicited and
UV-induced DNA damage
DNA repair is essential for maintenance of genome integ-
rity and ineﬃcient or defective repair leads indirectly to
genomic instability (21). We asked next whether EBV
DNase has the potential to aﬀect DNA repair. We
carried out HCR assay to investigate the eﬀect of
DNase on DNA repair (63). The HCR assay can easily
measure the capacity for DNA repair quantitatively for
various types of DNA damage (64,65). In the HCR assay,
either the empty vector or plasmid expressing DNase,
control plasmid pRL-CMV, and either a damaged or
untreated luciferase reporter plasmid (pCMV-Luc) were
cotransfected into TW01 epithelial cells. Because
DNA-damaging chemicals and UV are the most
common causes of damage used experimentally (63),
ﬁrst, we assayed the eﬀect of DNase on repair of
chemical-induced damage. Reporter plasmids were
treated with N-methyl-N0-nitro-N-nitrosoguanidine
(MNNG) or cisplatin for 3 h, puriﬁed on columns and
cotransfected with DNase or vector plasmid and the
internal control pRL-CMV. Surprisingly, compared to
the vector control, the cells transfected with DNase had
an eﬃciency of repair of the MNNG-damaged reporter
plasmids reduced to 0.78 at 24 h and 0.84 at 48 h
(P<0.05, t-test) in the TW01 cells (Figure 4a, left).
Similarly, DNase reduced cisplatin-elicited repair at 24
and 48 h (Figure 4a, middle). The eﬀect of DNase on
UV-induced repair was investigated to verify this phenom-
enon. Reporter plasmids were irradiated with UV before
transfection and, 24 and 48 h post-transfection, the cells
were harvested and examined by HCR assay. The repair
eﬃciency of the cells transfected with EBV DNase for the
Figure 2. Continued.
Figure 3. The nuclease activity of EBV DNase is important for the
eﬀect of DNA damage. (a) TW01 cells were transfected with vector,
DNase, Mutant 1, Mutant 2 and Mutant 3, respectively. After 24 h
transfection, cells were collected for detection of DNA damage. DNA
damage was analyzed by comet assay, which is as described in
‘Materials and Methods’ section. (b) The results of comet assay were
quantitated by visual scoring. Visual scores were presented as classes
0–4 which increase with the level of genomic DNA damage
(Supplementary Figure S1). All data presented represent the means
and the standard deviations of at least three independent experiments.
Two asterisks denote P<0.01.
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h and 0.65 at 48 h (P<0.05, t-test) compared to the vector
control (Figure 4a, right). Furthermore, similar results
were demonstrated in the DNase-inducible lines. After
24 and 48 h of mock treatment or IPTG induction,
repair of MNNG-, cisplatin- and UV-damaged DNA
was repressed signiﬁcantly in HB7 cells compared to
that in Hp30SS cells (data not shown). These results
showed that EBV DNase caused a distinct repression of
repair of DNA damage induced by various damaging
agents, suggesting that EBV DNase also uses an alterna-
tive pathway to induce genomic instability.
Furthermore, we determined whether the nuclease
activity of EBV DNase is important for repression of
DNA repair. Wild type and three mutants of EBV
DNase were transfected into TW01 cells and the HCR
assay was used to measure the repair eﬃciencies of chem-
ical- and UV-induced damage. As shown in Figure 4b,
compared to wild type DNase, all three activity-null
mutants were able to inhibit repair of MNNG- and
cisplatin-elicited DNA damage, showing that the
nuclease activity of EBV DNase was not important for
repression of chemical-elicited repair. In contrast,
surprisingly, the ability to inhibit UV damage-induced
repair was lost in all three mutants (Figure 4b). These
results indicated that, besides interference of DNA
repair by nuclease activity, another mechanism for repres-
sion may exist.
EBV DNase represses transcription and translation
of repair-related genes
For extrinsic nucleases, the cellular repair pathway is
activated by DNA damage which is sensed by cellular
repair systems (66). Chang et al. reported that the
APE suppressed MMR activity by repressing expression
of MSH6, which is one of the MMR genes (35).
Figure 4. EBV DNase represses repair of chemical- and UV-damaged DNA. (a) TW01 cells were cotransfected with 2 mg/well of empty vector or a
construct encoding DNase, together with a damaged or undamaged pCMV-luciferase reporter construct (pCMV-Luc, 0.1 mg/well) and Renilla
reporter construct (0.1mg/well). In the left panel, pCMV-Luc was pre-treated with MNNG (100 mM) for 3 h. In the middle panel, pCMV-Luc
was pre-treated with cisplatin (10 mg/ml) for 3 h. In the right panel, pCMV-Luc was exposed to UV (2000 J/m
2). Twenty-four hours and fourty-eight
hours after cotransfection, luciferase activity and Renilla intensity were determined. Relative fold of HCR represents DNA repair activity, calculated
as described in ‘Materials and Methods’ section. (b) TW01 cells were transfected with 2mg/well of vector, DNase, Mutant 1, Mutant 2 or Mutant 3,
together with an MNNG-treatment (100mM) for 3 h, or cisplatin-treated (10mg/ml), or UV-exposed (2000J/m
2), or undamaged pCMV-luciferase
reporter construct (pCMV-Luc) (0.1mg/well) and Renilla reporter construct (0.1mg/well), respectively. Forty-eight hours after cotransfection, HCR
assays were determined. Relative fold of HCR represents DNA repair activity, calculated as described in ‘Materials and Methods’ section. All data
presented represent the means and the standard deviations of at least three independent experiments. Asterisk denotes P<0.05.
1940 Nucleic Acids Research, 2010,Vol.38, No. 6In addition, MNNG and cisplatin treatment have been
shown to induce expression of MMR genes (67,68) and
MMR plays important roles in the repair of MNNG- and
cisplatin-generated adducts (67,69), although other repair
systems are also important in this process (67,70). To
determine whether EBV DNase aﬀects the protein expres-
sion levels of MMR repair genes, western blotting was
used to detect expression of four of them, MSH2,
MSH6, MLH1 and PMS2, in the parental, vector and
DNase-transfected TW01 cells. The results indicated a
decrease in the levels of MSH6 and MLH1 expression in
the DNase-transfected cells compared to the vector
control (P<0.05), but no decrease was detected in
MSH2 and PMS2 (Figure 5a). Although the decreased
expressions of MSH6 and MLH1 were not very
profound, it may be due to the transfection eﬃciency
was only around 50–60% (Supplementary Figure 4). To
investigate whether EBV DNase also can suppress expres-
sion of the repair genes in inducible lines, Hp30SS and
HB7 were treated with IPTG or not. Forty-eight hours
after induction, cells were harvested and the protein
expression of MMR genes was determined by western
blot analysis. Surprisingly, all four proteins from HB7
cells were expressed at signiﬁcantly decreased levels
compared to those from the Hp30SS vector controls
(Figure 5b). Similarly, in DNase-expressing H1299 cells,
MSH2 was decreased slightly and MSH6 was suppressed
markedly, compared to vector-expressing cells (data not
shown).
To investigate this phenomenon further, we measured
the concentrations of MSH2, MSH6, MLH1 and PMS2
mRNAs from DNase-expressing TW01 cells by QPCR to
investigate whether the transcription of MMR-related
genes was repressed. As shown in Figure 6a, the tran-
scripts of MSH6, MLH1 and PMS2 were decreased to
nearly 0.8-fold of vector control (P<0.05, t-test). This
result was consistent with the results of protein expression.
Concentrations of MMR mRNA were also quantiﬁed in
Hp3’SS and HB7 cells after 48 h induction with IPTG or
not. MSH2 expression was decreased the most (0.55-fold
of vector control, P<0.05, t-test) while expression of
MSH6, MLH1 and PMS2 decreased to 0.7–0.78-fold
compared with the vector control (P<0.05, t-test,
Figure 6b). The mRNA concentrations of four genes in
the IPTG-untreated Hp30SS and HB7 were similar to
IPTG-treated Hp30SS cells (data not shown). The
decreasing levels of RNA expression were not correlated
with protein expression in HB7 cells, although repression
of protein expression also had occurred. These unexpected
ﬁndings may result from speciﬁc diﬀerences between
Figure 5. EBV DNase decreases protein expressions of repair-related genes in epithelial cells. (a) In the left panel, 48 h post-transfection, the protein
extracts of DNase and the empty vector transfected TW01 cells, and the parental TW01 cells (Mock) were examined by western blot using MSH2,
MSH6, MLH1 and PMS2 antibodies. The detection of GAPDH was used as the loading control. In the right panel, the expression levels were
quantiﬁed by densitometry. After standardizing with loading control, they were expressed as the relative expression compared with the vector
controls. The values are a mean±SD from three separate experiments. Asterisk denotes P<0.05. (b) In the left panel, after 48 h IPTG
(20 mM) induction or mock-treated, the protein extracts of Hp30SS and HB7 were examined by western blot using MSH2, MSH6, MLH1 and
PMS2 antibodies. The detection of GAPDH was used as the loading control. In the right panel, the expression levels were quantiﬁed. After
standardization with loading control, they were expressed as the relative expression compared to those from the Hp30SS vector controls. The
values are a mean ±SD from three separate experiments. Asterisk denotes P<0.05.
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activity on the decreased mRNA of these repair genes,
we further detected the mRNA expressions of these
genes in Mutants 1, 2 and 3-transfected TW01 cells. The
mRNA levels of repair genes in Mutants 1, 2 and
3-transfected TW01 cells were similar to that of wild
type DNase-transfected cells (data not shown). This
result suggested that DNase activity may not be
involved in decreased expression of repair genes.
The repression of expression of MMR-related genes at
the mRNA and protein levels prompted us to ask whether
expression of other repair-related genes also was aﬀected
by EBV DNase. To evaluate this possibility, several
repair-related genes were selected to investigate their
mRNA expression in the mock-treated and IPTG-
treated Hp30SS and HB7 cells. As shown in Table 2, as
well as the MMR-related genes, almost all of the selected
genes were decreased. Among the NER-related genes,
ERCC1 was decreased signiﬁcantly compared to the
control (0.38-fold of control, P<0.01, t-test) and XPF
was decreased 0.8-fold compared to the vector control
(P<0.05, t-test). However, XPA and XPB were not
signiﬁcantly down-regulated. Among the BER-related
genes, CSA and CSB were reduced 0.68- and 0.77-fold
compared to the vector controls (P<0.05, t-test).
Among the HR-related genes, expression of BRCA2 and
Rad51 also was down-regulated 0.8- and 0.58-fold
compared to the vector controls (P<0.05, t-test). These
results revealed that EBV DNase can suppress the expres-
sion of various repair-related genes and thus diminish
cellular repair activities, however, it could not
down-regulate all of the NER- related genes, which may
imply certain target speciﬁcity.
The function of host-shut oﬀ of EBV DNase may
contribute in repression of DNA repair
Recently, EBV DNase and its homolog KSHV SOX were
demonstrated to shut-oﬀ universal host mRNA in
expressing cells (71,72), and thus aﬀect cellular functions.
We then addressed whether the function of host shut-oﬀ
of EBV DNase plays an important role in repression of
DNA repair. Several groups had deﬁned the important
host shut-oﬀ residues of gammaherpesviral DNases
(73,74). Based on these data, we cloned two host
shut-oﬀ-null mutants, which were designated as HS
mutant (K231M) and M3/HS mutant (E225A/K227A/
F452A/K231M), to perform further experiments
(Supplementary Figure 2a and b). After conﬁrming by
DNA sequencing, DNase activity and protein expression
of these mutants were detected (Supplementary Figure 2c
and d). The results revealed that HS mutant had DNase
activity but M3/HS mutant did not (Supplementary
Figure 2c). In addition, mRNAs of several repair genes
were detected. As shown in Figure 7a, compared to wild
type and Mutant 3, HS and M3/HS mutants had lost the
ability to down-regulate repair genes MSH6, MLH1 and
PMS2. This loss of host shut-oﬀ ability was compatible
with previous studies by others (72,74) and obviously
aﬀected the repression of cellular repair activity
(Figure 7b).
Finally, we tried to deﬁne the importance of host
shut-oﬀ in DNase-induced genomic instability. As shown
in Figure 7c, mutants which defected in DNase activity
also signiﬁcantly decreased the ability of MN induction
(Mutant 3 and M3/HS mutant). However, since Mutant
3 had a little increase and M3/HS mutant had no signif-
icant eﬀect compared to vector control suggesting host
shut-oﬀ has a little contribution to MN formation.
These results provided the strong evidence that, in EBV
DNase-inducing genomic instability, DNA damage plays
a major role and repair repression is a cooperative and
auxiliary role.
In conclusion, these results indicate host shut-oﬀ may
contribute partly in the induction of genomic instability,
although its eﬀect is relatively weaker.
EBV DNase increases chromosomal aberrations
Because, based on MN formation, EBV DNase could
induce genomic instability, we investigated whether EBV
DNase had the ability to cause chromosomal aberration
(CA). To this end, TW01 cells transfected EBV DNase or
Figure 6. EBV DNase decreases mRNA amounts of MMR-related
genes in epithelial cells. (a) Forty-eight hours post-transfection, total
RNA of DNase and the empty vector transfected TW01 cells, and the
parental TW01 cells were extracted. After RT, cDNA were examined
for the mRNA expression of MSH2, MSH6, MLH1 and PMS2. The
detection of GAPDH was used as the control. The expression level of
each sample was standardized with that of GAPDH and then expressed
as the relative expression compared to the vector controls. (b) After 48
h IPTG (20 mM) induction, total RNA of Hp30SS and HB7 cells were
extracted. After RT, cDNA were examined for the mRNA expression
of MSH2, MSH6, MLH1 and PMS2. The detection of GAPDH was
used as the control. The expression level of each sample was
standardized with that of GAPDH and expressed as the relative expres-
sion compared to the decreased levels of vector controls. In all of
results, the values are a mean ±SD from at least three separate exper-
iments. Asterisk denotes P<0.05.
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including dicentric chromosomes, chromosome fragments,
chromatid gaps, chromosome rings, double minutes and
satellite associations were scored in 200 metaphase plates
of each vector and DNase transfected TW01 cells. As
shown in Figure 8, the cells transfected with DNase had
higher CA than the vector control in terms of chromo-
some fragments, gaps and satellite associations. The
results of chromosome analysis showed that EBV DNase
had the ability to enhance chromosome aberrations.
EBV DNase causes microsatellite instability and
genetic mutation
Because EBV DNase can induce DNA strand breaks,
inhibit DNA repair and chromosome aberrations, it was
assumed to act as a mutagen. We carried out a mutation
assay to investigate whether the expression of EBV DNase
causes genetic mutation and MSI. Hp30SS (a vector
control) and HB7 (wild-type) cells were transfected with
two plasmids, pBsd2-puro and pBsd4-puro. After
transfection in HEp2 cells, the transfectants were
selected with puromycin (1mg/ml). Puromycin-resistant
clones emerged 2-3 weeks later and were designated
Hp30SS/pBsd2, Hp30SS/pBsd4, HB7/pBsd2 and HB7/
pBsd4. Parental HEp2 cells did not grow in the presence
of blasticidin (5mg/ml) (survival ratio<10
 6). These
transfectants were incubated with IPTG to induce
DNase expression for 6 days and selected with blasticidin
(5mg/ml) for 14 days (Figure 9a and 9b). If genetic muta-
tions (for pBsd2-puro: TAG changed to ATG and for
pBsd4-puro: out-frame shifted to in-frame) did occur,
these cells would become blasticidin resistant and grow
in the presence of blasticidin. As a consequence, the
blasticidin resistant colonies were considered to have
genetic mutations. We found that the mutation rates
obtained from the DNase-induced cells were increased to
1.95 and 2.66-fold for HB7/pBsd2 and HB7/pBsd4,
respectively (P<0.01) (Figure 9c). These data indicated
that expression of EBV DNase is able to cause genetic
mutations. Because these mutations also may have
resulted from MSI, we propose that EBV DNase may
induce DNA mutation, MSI and lead to a mutator
phenotype.
DISCUSSION
In this study, EBV DNase, a member of viral ANs, was
transfected into human epithelial cells, TW01, H1299 and
HEp2. The results indicate that EBV DNase could induce
genomic instability in various human epithelial cells
(Figure 1a). This phenomenon was further corroborated
with the results obtained from DNase inducible cells
(Figure 1b). DNA damage and repression of DNA
repair may contribute to the induction of genomic insta-
bility. Using gH2AX formation and comet assay, we
found that EBV DNase is able to induce DNA strand
breaks in transient transfection and inducible DNase
expression system (Figures 2 and 3). By HCR, EBV
DNase was able to repress repair of DNA damage by
both chemical treatments (MNNG and cisplatin) and
UV irradiation (Figure 4). Through western blot and
QPCR, expressions of repair-related genes were reduced
in transient expression and inducible DNase expressing
cells (Figures 5 and 6). We further performed QPCR to
quantitate relative expression of repair-related genes in
EBV DNase expressing cells and found many of genes
involved in MMR, NER, BER/TCR and HR were
reduced in their expressions (Table 2). These results
provide a possible mechanism for viruses carrying ANs
in the carcinogenesis of human cancers.
It is conceivable that a protein possesses DNase activity
would damage DNA. gH2AX formation is an immediate
early step after the occurrence of DNA DSBs (75). In our
study, EBV DNase increased phosphorylation of H2AX
in a dose-dependent manner (Figure 2a). Furthermore,
activity-null mutants were found to be less eﬀective in
the induction of DNA damage (Figure 3). These results
provided strong evidence that nuclease activity is impor-
tant for induction of DNA damage.
Repression of DNA repair may result in genomic insta-
bility (21). It was surprising for us to ﬁnd EBV DNase
repressed HCR in this study (Figure 4). Although it
revealed that inhibition of DNA repair seemed just only
play as an auxiliary worker in the process of
DNase-induced genomic instability (Figure 7), it would
be interesting to see by what mechanism(s) did EBV
DNase repress these cellular repair activities? Several
lines of evidence suggested that appropriate expression
of nucleases increased repair activities and is beneﬁcial
to the maintenance of genome integrity (76–78),
however, other investigations supported the concept that
expression of nucleases would not only repress repair
activity but also increase the mutation rate (34,35,79).
Furthermore, ectopic expression of restriction
endonucleases may increase repair activities because of
DNA damage (80). In our experiments, EBV DNase
clearly down-regulated chemical- and UV-induced repair
Table 2. Relative expression of repair-related genes in EBV
DNase-expressing cells
Repair-related genes Decrease folds of
mRNA (mean±SD)
MMR
MSH2 0.546±0.152*
MSH6 0.779±0.083*
MLH1 0.700±0.022*
PMS2 0.781±0.075*
NER
ERCC1 0.384+0.360**
XPA 0.992+0.083
XPB 0.934±0.054
XPF 0.796+0.045*
BER/TCR
CSA 0.678±0.102*
CSB 0.765±0.045*
HR
BRCA2 0.793±0.030*
Rad51 0.577±0.027*
The values are a mean ±SD from at least three separate experiments.
*P<0.05.
**P<0.01.
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repair mechanisms were likely impaired in these cells.
The damage signal was probably activated, because
H2AX was phosphorylated (Figure 2), however, repair
activity was suppressed at the same time (Figure 4). It
can be speculated repression of DNA repair overwhelmed
the damage signaling. The ﬁnding that repression of repair
resolved slightly from 24 to 48h may support the
possibility that increasing strength of damage signal
overcame the DNA repair-repressing eﬀect of EBV
DNase (Figure 4). In addition, because down-regulation
of repair-related components would decrease repair
activity signiﬁcantly, the result of down-regulation of
repair-related proteins by EBV DNase may explain how
chemical- and UV-induced repair repression occurred
(Figures 5 and 6, Table 2). Interestingly, the nuclease
Figure 7. Host shut-oﬀ mutants do not induce repair repression but the mutants with DNase activity induce MN formation in epithelial cells.
(a) Total RNAs of vector, DNase and mutants transfected TW01 cells were extracted 48h post-transfection. After RT, cDNA were examined for the
mRNA expression of MSH6, MLH1 and PMS2 with GAPDH as the internal control. Then the relative expression compared to the vector control
was presented. The values are a mean±SD from at least three separate experiments. (b) TW01 cells were cotransfected with 2mg/well of empty
vector or a construct encoding DNase, together with a damaged or undamaged pCMV-luciferase reporter construct (pCMV-Luc, 0.1mg/well) and
Renilla reporter construct (0.1mg/well). pCMV-Luc was pre-treated with cisplatin (10mg/ml) for 3h. Luciferase activity and Renilla intensity were
determined 48h after cotransfection. Relative fold of HCR represents DNA repair activity, calculated as described in ‘Materials and Methods’
section. (c) TW01 cells were transfected with vector control, DNase and mutants-expressing plasmids. Cells were harvested and were stained by
Hoechst for counting micronuclei 24h post-transfection. The values are a mean±SD from at least three separate experiments. In all of results,
asterisk denotes P<0.05.
1944 Nucleic Acids Research, 2010,Vol.38, No. 6activity of EBV DNase appeared to be important for
repair of UV-damaged DNA, but not for repair of
MNNG- and cisplatin-induced damage (Figure 4).
Because NER was suggested to be involved mostly in
repairing UV-damaged DNA, these ﬁndings imply that
the nuclease activity of EBV DNase interferes with the
NER pathway. However, since EBV DNase interfered
NER, BER or MMR expressions diﬀerently (Table 2),
the detailed roles that the nuclease plays in diﬀerent
repair processes require careful clariﬁcation.
Another interesting question can be raised. How did
EBV DNase repress expression of these repair-related
genes? Three possible mechanisms may be considered.
First, EBV DNase may eliminate expression of
repair-related genes through turnover of mRNA. It has
been shown that EBV DNase blocks the synthesis of
HLA class I and II by eliminating mRNAs (72). Our
results showing that EBV DNase inhibits expression of
repair genes support this possibility (Table 2).
Furthermore, as shown in Figure 7, compared to wild
type, although host shut-oﬀ mutant HS increased approx-
imately similar level of MN formation, which suggested
that host shut-oﬀ may not be important for induction of
genomic instability, however, Mutant 3 lost DNase
activity but keeping host shut-oﬀ function still increased
little but signiﬁcant level of MN formation. Of note, EBV
DNase likely did not inhibit all repair gene expression
(Table 2). This implies that EBV DNase may act
preferentially on mRNA turnover. We also measured by
QPCR the amounts of mRNA of the housekeeping genes
GAPDH, b-actin and p53 which were normalized with the
amount of 18S RNA (Supplementary Figure 5a). Results
showed that the amount of GAPDH RNA of
IPTG-treated HB7 cells is almost equal to that of
mock-treated HB7, while that of b-actin and p53
decreased in the cells under IPTG induction
(Supplementary Figure S5a). Western blot indicated that
levels of the protein expressions from b-actin and
GAPDH were coincident with that of mRNA by QPCR
(Supplementary Figure S5b). This is also why we used
GAPDH as internal control in the host shut-oﬀ experi-
ments. Similarly, an earlier report suggested that the
DNase of KSHV aﬀected mRNA turnover (71).
Microarray data revealed that a small population of
host mRNA escaped elimination by KSHV DNase (81).
These results demonstrated that host shut-oﬀ may con-
tribute in repair repression auxiliarily (Figure 7).
Unfortunately, so far, we do not know which mRNAs
are eliminated preferentially by the g-herpesvirus
DNases. Recently, Lee et al. suggested that aberrant
herpesvirus –induced polyadenylation correlates with
host shut-oﬀ function (82). These studies revealed that
the precise mechanism(s) of RNA turnover may be quite
complex and thus far they remain unclear.
Secondly, overexpression of APE alone reduced MMR
function markedly and increased MSI through repression
of MSH6 expression (35). Ectopic expression of E. coli
exonuclease III repressed certain repair activities in the
breast cancer cells (83). These reports suggested that
unbalanced expression of nucleases may repress expres-
sion of repair proteins, disturb cellular repair pathways,
Figure 8. DNase induces chromosomal aberrations in epithelial cells.
Chromosomal aberrations, including dicentric chromosomes, chromo-
some fragments, chromatid gaps, chromosome rings, double minutes
and satellite associations were scored in 200 metaphase plates of
DNase-expressing cells and vector control. The frequency of chromo-
somal aberrations was represented as the percentage of scoring
metaphase plates.
Figure 9. EBV DNase enhances MSI and gene mutation. (a) Schematic
representation of treatment with IPTG and blasticidin. Hp30SS and
HB7 cells were transfected with pBsd2-puro or pBsd4-puro, respec-
tively, and then transfectants were selected with puromycin (1mg/ml).
Puromycin-resistant cells were collected and treated with 10mM of
IPTG or not for 6 days. These cells were maintained at a density
of 2 10
3 or 1 10
4 cells per 100- mm culture dishes in the presence
of blasticidin (5mg/ml). After 14 days of incubation, the cells were
stained with 0.05% p-iodonitrotetrazolium violet dye and then
colonies larger than 1 mm were counted. (b) Hp30SS or HB7 cells
were transfected with pBsd2-puro or pBsd4-puro, and
puromycin-resistant cells were mock treated (lanes 1, 3, 5 and 7) or
treated with IPTG (lanes 2, 4, 6 and 8) for 24h. Cell lysates were
analyzed by western blotting with antibodies against EBV DNase and
b-actin. (c) The frequency of gene mutation was calculated by dividing
the number of blasticidin-resistant colonies by the number of cells
seeded. The relative fold changes indicate the frequency of gene
mutation in the presence of IPTG, calculated by dividing by that in
the absence of IPTG. The values are a mean±SD from three separate
experiments. Two asterisks denote P<0.01.
Nucleic Acids Research,2010, Vol.38, No. 6 1945and increase genomic instability and genetic mutation. On
this basis, it is possible that unbalanced expression of EBV
DNase may cause down-regulation of repair proteins,
disturb repair systems, and eventually repress repair
activity.
Finally, we cannot rule out the possibility that EBV
DNase may destroy the genes that are responsible for
repair. However, if this is the case, it would be diﬃcult
to explain how activity-null mutants repressed chemical-
elicited repairs (Figure 4b). On other hand, the ﬁnding
that the luciferase-reporter genes were also detectable by
PCR provided more indirect evidence to suggest that EBV
DNase may not destroy large numbers of repair-related
genes (data not shown). This interesting question is worth
further investigation.
EBV, KSHV, hepatitis B virus (HBV), HCV, HTLV
and HPV infections are considered to be associated with
the development of various human cancers (84). All these
viral-associated human malignancies possess signiﬁcant
genomic instabilities and chromosomal aberrations.
Genetic changes in these malignancies have been linked
explicitly to the virus infections and expression of viral
proteins. HTLV Tax has been suggested to inhibit BER
by interfering with DNA polymerase b (85) and thereby
induce increase of MN formation (86). HBV HBx dimin-
ished NER by interacting with UV-damaged binding
protein (87) and could induce MN formation (88). HBV
preS also has been shown to cause oxidative DNA damage
by generating endoplasmic reticulum stress (89). HCV has
been shown to induce DNA damage or mutation through
expression of the core protein or nonstructural protein 3
(27,49,90). In addition, HPV E6/E7 has been shown to
induce numerical chromosome instability (91,92) and E6
was suggested to inhibit NER and BER by E6-mediated
interfering with DNA repair proteins (93). In the
herpesviruses, the KSHV latent protein LANA plays an
important role in induction of chromosomal instability
(94). Moreover, regarding the EBV latent proteins,
LMP1 was reported to induce genomic instability
through repression of NER (47,95), EBNA 1 induces
genomic instability via induction of reactive oxygen
species (96) and EBNA2 and EBNA3C disrupt the
mitotic checkpoint and causes chromosomal instability
(97,98). Among these viral gene products, most are
involved in the generation of genomic instability by induc-
tion of DNA damage indirectly, repression of DNA
repair, and disturbance of DNA replication and
cytokinesis. However, we ﬁnd that EBV DNase is
unique in that it may contribute both through direct
induction of DNA damage and indirect repression of
DNA repair leading to increased chromosomal alteration
(Figure 8), gene mutation and MSI (Figure 9).
Interestingly, it was found that lytic proteins were
expressed immediately but transiently in virus primary
infection (99,100).This phenomenon implies that EBV
lytic proteins may have chance to ‘hit’ or ‘aﬀect’ cellular
DNA in the temporary expression and then play an
important role in the subsequent carcinogenesis. Our
results provide a new paradigm of a viral protein which
may contribute to the carcinogenesis of human
malignancies.
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